{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:19:15Z","timestamp":1780489155098,"version":"3.54.1"},"reference-count":72,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2019.00339","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T05:19:37Z","timestamp":1565673577000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Safety and Efficacy of Pneumococcal Vaccination in Pediatric Nephrotic Syndrome"],"prefix":"10.3389","volume":"7","author":[{"given":"Shamitha Thishakya","family":"Goonewardene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calyn","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loh Teng-Hern","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kok-Gan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithvy","family":"Lingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Learn-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bey-Hing","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyia","family":"Pusparajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00467-013-2567-8","article-title":"The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications","volume":"29","author":"Cadnapaphornchai","year":"2014","journal-title":"Pediatr Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/jpc.12734","article-title":"Childhood nephrotic syndrome in the 21st century: what's new?","volume":"51","author":"Metz","year":"2015","journal-title":"J Paediatr Child Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1542\/pir.36-3-117","article-title":"Nephrotic syndrome","volume":"36","author":"Andolino","year":"2015","journal-title":"Pediatr Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00467-010-1537-7","article-title":"Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndrome","volume":"25","author":"Andersen","year":"2010","journal-title":"Pediatr Nephrol."},{"key":"B6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1542\/peds.69.2.219","article-title":"Serum antibody-response to pneumococcal vaccine in children with nephrotic syndrome","volume":"69","author":"Spika","year":"1982","journal-title":"Pediatrics."},{"key":"B7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000185210","article-title":"Pneumococcal polysaccharide immunization in patients with active nephrotic syndrome","volume":"50","author":"Garin","year":"1988","journal-title":"Nephron."},{"key":"B8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/MNH.0b013e328354a681","article-title":"Soluble urokinase receptor and focal segmental glomerulosclerosis","volume":"21","author":"Reiser","year":"2012","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","article-title":"Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children","volume":"24","author":"Kamei","year":"2009","journal-title":"Pediatr Nephrol."},{"key":"B10","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization\u2014WHO position paper","volume":"82","year":"2007","journal-title":"Weekly Epidemiol Record."},{"key":"B11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3345\/kjp.2011.54.8.322","article-title":"Complications of nephrotic syndrome","volume":"54","author":"Park","year":"2011","journal-title":"Kor J Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s004670050710","article-title":"Microbiological spectrum of septicemia and peritonitis in nephrotic children","volume":"13","author":"Tain","year":"1999","journal-title":"Pediatr Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.7774\/cevr.2015.4.2.121","article-title":"Pneumococcal disease and use of pneumococcal vaccines in Taiwan","volume":"4","author":"Wei","year":"2015","journal-title":"Clin Exp Vacc Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/archpedi.1982.03970440076023","article-title":"Peritonitis in childhood nephrotic syndrome: 1970-1980","volume":"136","author":"Krensky","year":"1982","journal-title":"Am J Dis Child."},{"key":"B15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00431-009-0989-x","article-title":"Primary peritonitis in children with nephrotic syndrome: results of a 5-year multicenter study","volume":"169","author":"Uncu","year":"2010","journal-title":"Eur J Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1016\/j.vaccine.2016.05.043","article-title":"The impact of a pneumococcal conjugate vaccination program on the nasopharyngeal carriage, serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among healthy children in Turkey","volume":"34","author":"Soysal","year":"2016","journal-title":"Vaccine."},{"key":"B17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1172-7-42","article-title":"Complement factor I deficiency: a not so rare immune defect. Characterization of new mutations and the first large gene deletion","volume":"7","author":"Alba-Dom\u00ednguez","year":"2012","journal-title":"Orphanet J Rare Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1056\/NEJMc1306326","article-title":"Deficiency in complement factor B","volume":"369","author":"Slade","year":"2013","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1203\/00006450-197708000-00012","article-title":"Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome","volume":"11","author":"Mclean","year":"1977","journal-title":"Pediatr Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00006454-199603000-00012","article-title":"Urinary tract infection in nephrotic syndrome","volume":"15","author":"Gulati","year":"1996","journal-title":"Pediatr Infect Dis J."},{"key":"B21","first-page":"61","article-title":"Correlations between serum factor B and C3b inactivator levels in normal subjects and in patients with infections, nephrosis and hypocomplementaemic glomerulonephritis","volume":"28","author":"Forristal","year":"1977","journal-title":"Clin Exp Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1442-200X.1998.tb01942.x","article-title":"Serum levels of C3 and factors I and B in minimal change disease","volume":"40","author":"Patiroglu","year":"1998","journal-title":"Pediatr Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.vaccine.2007.11.049","article-title":"The role of complement in the success of vaccination with conjugated vs. unconjugated polysaccharide antigen","volume":"26","author":"Salehan","year":"2008","journal-title":"Vaccine."},{"key":"B24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/archpedi.1982.03970440057016","article-title":"T-cell dysfunction in minimal-change nephrotic syndrome of childhood","volume":"136","author":"Fodor","year":"1982","journal-title":"Am J Dis Child."},{"key":"B25","first-page":"176","article-title":"Impaired lymphocyte and suppressor cell function in minimal change nephropathy, membranous nephropathy and focal glomerulosclerosis","volume":"22","author":"Taube","year":"1984","journal-title":"Clin Nephrol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00467-001-0817-7","article-title":"Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome","volume":"17","author":"Kemper","year":"2002","journal-title":"Pediatr Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1440-1754.1998.00232.x","article-title":"Prevention of serious bacterial infection in children with nephrotic syndrome","volume":"34","author":"Mcintyre","year":"1998","journal-title":"J Paediatr Child Health."},{"key":"B28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nephro.2010.03.003","article-title":"[Physiopathology and treatment of nephrotic syndrome complications]","volume":"7","author":"Ducloux","year":"2011","journal-title":"Nephrol Therapeut."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00467-015-3241-0","article-title":"The non-immunosuppressive management of childhood nephrotic syndrome","volume":"31","author":"Mccaffrey","year":"2016","journal-title":"Pediatr Nephrol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0272-6386(86)80088-9","article-title":"Splenic hypofunction in the nephrotic syndrome of childhood","volume":"7","author":"Mcvicar","year":"1986","journal-title":"Am J Kidney Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/BF00862600","article-title":"Normal splenic function in children with the nephrotic syndrome","volume":"2","author":"Berns","year":"1988","journal-title":"Pediatr Nephrol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s004670000523","article-title":"A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children","volume":"16","author":"Latta","year":"2001","journal-title":"Pediatr Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1093\/infdis\/137.6.818","article-title":"Antibody response to capsular polysaccharide vaccine of Streptococcus pneumoniae in patients with nephrotic syndrome","volume":"137","author":"Fikrig","year":"1978","journal-title":"J Infect Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0272-6386(82)80042-5","article-title":"Response to pneumococcal vaccination in children with nephrotic syndrome","volume":"2","author":"Wilkes","year":"1982","journal-title":"Am J Kidney Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000166769","article-title":"Persistence of protective pneumococcal antibody following vaccination in patients with the nephrotic syndrome","volume":"4","author":"Tejani","year":"1984","journal-title":"Am J Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0272-6386(86)80186-X","article-title":"Decline of vaccine-induced antipneumococcal antibody in children with nephrotic syndrome","volume":"7","author":"Spika","year":"1986","journal-title":"Am J Kid Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/0264-410X(95)00093-G","article-title":"Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection","volume":"13","author":"Lee","year":"1995","journal-title":"Vaccine."},{"key":"B38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00467-003-1331-x","article-title":"Rapid decline of anti-pneumococcal antibody levels in nephrotic children","volume":"19","author":"Guven","year":"2004","journal-title":"Pediatr Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00467-008-0782-5","article-title":"High serological response to pneumococcal vaccine in nephrotic children at disease onset on high-dose prednisone","volume":"23","author":"Ulinski","year":"2008","journal-title":"Pediatr Nephrol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00467-010-1492-3","article-title":"Polysaccharide pneumococcal vaccination of nephrotic children at disease onset-long-term data","volume":"25","author":"Aoun","year":"2010","journal-title":"Pediatr Nephrol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s00467-012-2273-y","article-title":"Do vitamin D plasma levels impact vaccine response in children with idiopathic nephrotic syndrome?","volume":"27","author":"Aoun","year":"","journal-title":"Pediatr Nephrol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1016\/j.vaccine.2011.07.053","article-title":"Safety, immunogenicity and kinetics of immune response to 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome","volume":"29","author":"Liakou","year":"2011","journal-title":"Vaccine."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.vaccine.2013.11.106","article-title":"Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome","volume":"32","author":"Liakou","year":"2014","journal-title":"Vaccine."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1016\/j.vaccine.2016.08.049","article-title":"Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccine","volume":"34","author":"Pittet","year":"2016","journal-title":"Vaccine."},{"key":"B45","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/S0272-6386(12)80899-7","article-title":"Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome","volume":"24","author":"Ogi","year":"1994","journal-title":"Am J Kidney Dis."},{"key":"B46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1542\/peds.81.6.849","article-title":"Peritonitis in children with nephrotic syndrome","volume":"81","author":"Gorensek","year":"1988","journal-title":"Pediatrics."},{"key":"B47","volume-title":"Red Book: 2012 Report of the Committee on Infectious Diseases.","author":"Pickering","year":"2012"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1001\/archinte.1994.00420230051007","article-title":"Efficacy of pneumococcal vaccination in adults: a meta-analysis of randomized controlled trials","volume":"154","author":"Fine","year":"1994","journal-title":"Arch Int Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J."},{"key":"B50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0891-5245(01)58585-5","article-title":"Prevnar (heptavalent pneumococcal conjugate vaccine): disease prevention in infants and children","volume":"15","author":"Shields","year":"2001","journal-title":"J Pediatr Health Care."},{"key":"B51","first-page":"258","article-title":"Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children\u2014Advisory Committee on Immunization Practices (ACIP), 2010","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B52","first-page":"1725","article-title":"Vaccine immunology","volume":"5","author":"Siegrist","year":"2008","journal-title":"Vaccine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1542\/peds.101.4.604","article-title":"Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants","volume":"101","author":"Rennels","year":"1998","journal-title":"Pediatrics."},{"key":"B54","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/00006454-200004000-00035","article-title":"Immunogenicity of pneumococcal conjugate vaccines","volume":"19","author":"Eskola","year":"2000","journal-title":"Pediatr Infect Dis J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/cid\/cis354","article-title":"Effectiveness and serotype coverage: key criteria for pneumococcal vaccines for adults","volume":"55","author":"Grabenstein","year":"2012","journal-title":"Clin Infect Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"CD004977","DOI":"10.1002\/14651858.CD004977.pub2","article-title":"Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and X-ray defined pneumonia in children less than two years of age","volume":"7","author":"Lucero","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"B57","unstructured":"John Hopkins Bloomberg School of Public Health International Vaccine Access Center. View-Hub Report: Global Vaccine Introduction and Implementation.2018"},{"key":"B58","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1513\/AnnalsATS.201511-778FR","article-title":"Pneumococcal vaccination strategies. An update and perspective","volume":"13","author":"Berical","year":"2016","journal-title":"Ann Am Thoracic Soc."},{"key":"B59","doi-asserted-by":"publisher","first-page":"197","DOI":"10.15167\/2421-4248\/jpmh2009.50.4","article-title":"Childhood pneumococcal vaccination in Europe","volume":"50","author":"Lopalco","year":"2009","journal-title":"J Prev Med Hyg."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1542\/peds.2014-2811","article-title":"Immunization for Streptococcus pneumoniae infections in high-risk children","volume":"134","author":"Brady","year":"2014","journal-title":"Pediatrics."},{"key":"B61","unstructured":"CDC Vaccine Price List.2019"},{"key":"B62","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1001\/jama.2012.169","article-title":"Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine","volume":"307","author":"Smith","year":"2012","journal-title":"JAMA."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e010776","DOI":"10.1136\/bmjopen-2015-010776","article-title":"Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model","volume":"6","author":"Delgleize","year":"2016","journal-title":"BMJ Open."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2214-109X(18)30422-4","article-title":"Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis","volume":"7","author":"Chen","year":"2019","journal-title":"Lancet Global Health."},{"key":"B65","first-page":"512","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6\u201318 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","author":"Bennett","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"B66","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1346-8138.2003.tb00380.x","article-title":"Pityriasis rosea-like eruption due to pneumococcal vaccine in a child with nephrotic syndrome","volume":"30","author":"Sasmaz","year":"2003","journal-title":"J Dermatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"CD003964","DOI":"10.1002\/14651858.CD003964.pub2","article-title":"Interventions for preventing infection in nephrotic syndrome","volume":"4","author":"Wu","year":"2004","journal-title":"Cochrane Library."},{"key":"B68","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","article-title":"Th1 and Th2 cytokine mRNA profiles in childhood Nephrotic Syndrome evidence for Increased IL-13 mRNA expression in relapse","volume":"10","author":"Yap","year":"1999","journal-title":"J Am Soc Nephrol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1016\/j.vaccine.2013.10.024","article-title":"Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions","volume":"31","author":"Cho","year":"2013","journal-title":"Vaccine."},{"key":"B70","doi-asserted-by":"publisher","first-page":"701","DOI":"10.18553\/jmcp.2011.17.9.701","article-title":"Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital","volume":"17","author":"Smith","year":"2011","journal-title":"J Manag Care Pharm."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1542\/peds.2014-2512","article-title":"Improving pneumococcal vaccination in pediatric rheumatology patients","volume":"136","author":"Harris","year":"2015","journal-title":"Pediatrics."},{"key":"B72","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJM198009043031003","article-title":"Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine","volume":"303","author":"Broome","year":"1980","journal-title":"N Engl0 J Med."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00339\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T14:21:00Z","timestamp":1664115660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fped.2019.00339\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":72,"alternative-id":["10.3389\/fped.2019.00339"],"URL":"https:\/\/doi.org\/10.3389\/fped.2019.00339","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]},"article-number":"339"}}